A recombinant subunit vaccine for SARS-CoV-2

Accessibility Controls

Implementing Organization

Indian Institute of Science

Principal Investigator

Prof Raghavan Varadarajan

Indian Institute of Science (IISc), Bengaluru

Project Overview

The goal is to develop a rapidly producible vaccine for protection to front-line health workers, senior citizens and individuals with co-morbidities such as cardiovascular disease and diabetes.

Related Research

View All

Quick Information

Area of Research

Life Sciences & Biotechnology

Focus Area

COVID-19 Vaccine Development

Start Date

2020

Sanction Amount

₹ 15.00 Cr

Contact

varadar@iisc.ac.in

Output

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

Publications

No. of Patents

Filed : 00

Grant : 00

Accessibility Controls

Research Projects